Key statistics
On Friday, Eupraxia Pharmaceuticals Inc (EPRX:NAQ) closed at 2.87, 20.26% above the 52 week low of 2.39 set on Aug 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.90 |
---|---|
High | 2.94 |
Low | 2.82 |
Bid | 2.79 |
Offer | 3.15 |
Previous close | 2.80 |
Average volume | 4.55k |
---|---|
Shares outstanding | 35.62m |
Free float | 33.15m |
P/E (TTM) | -- |
Market cap | 137.26m CAD |
EPS (TTM) | -1.36 CAD |
Data delayed at least 15 minutes, as of Sep 20 2024 20:46 BST.
More ▼
Press releases
- Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases
- Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
- Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Eupraxia Pharmaceuticals Announces New C$12 Million Convertible Debt Facility
- Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo
- Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024
More ▼